S. Jurado Zapata
E. Van den Akker
A. Barton
P. Brown
A. Cope
I. Gonzlez-lvaro
C. Goodyear
X. Hu
T. Huizinga
M. Johannesson
L. Klareskog
D. Lendrem
I. McInnes
F. Morton
C. Paterson
D. Porter
A. Pratt
L. Rodriguez Rodriguez
D. Sieghart
P. Studenic
S. Verstappen
L. Padyukov
A. Winkler
J. D. Isaacs
R. Knevel
Leiden University Medical Centre, Leiden, Netherlands
Janssen Pharmaceutical Companies of Johnson & Johnson, Discovery Science/Computational Biology, Beerse, Belgium
Leiden University Medical Center, Leiden Computational Biology Center, Leiden, United Kingdom
School of Biological Sciences The University of Manchester, Division of Musculoskeletal and Dermatological Sciences, Manchester, United Kingdom
Newcastle University, Institute of Cellular Medicine, Newcastle Upon Tyne, United Kingdom
King’s College London Centre for Rheumatic Diseases, Department of Inflammation Biology, London, United Kingdom
Hospital Universitario de la Princesa-IP, Immunology, Madrid, Spain
University of Glasgow, Glasgow, United Kingdom
Pfizer, Inflammation & Immunology Research Unit, Cambridge, United States of America
Karolinska Institutet and Karolinska University Hospital, Reproductive Medicine, Stockholm, Sweden
Newcastle upon Tyne Hospitals NHS Foundation Trust, Health and Bioinformatics, Newcastle upon Tyne, United Kingdom
University of Glasgow, Institute of Infection Immunity and Inflammation, Glasgow, United Kingdom
Hospital Clinico San Carlos, Department of Rheumatology, Madrid, Spain
Medical University of Vienna, Vienna, Austria
Netherlands
Belgium
United Kingdom
Spain
United States
Sweden
Austria
N/A
Autoimmune (AI)
Rheumatoid arthritis
N/A
N/A
N/A
Cohort
NA
N/A
Pfizer
N/A